Advertisement
Advertisement

ANRO

ANRO logo

Alto Neuroscience Inc.

3.66
USD
-0.13
-3.43%
Dec 18, 15:59 UTC -5
Closed
...

Alto Neuroscience Inc. Profile

About

Alto Neuroscience Inc. is a clinical-stage biopharmaceutical company. Its clinical-stage pipeline includes novel drug candidates in depression, PTSD, schizophrenia and other mental health conditions. Alto Neuroscience Inc. is based in LOS ALTOS, Calif.

Info & Links

CEO

Amit Etkin

Headquarters

369 SOUTH SAN ANTONIO RD.
LOS ALTOS, CA 94022, UNITED STATES

Auditor

Deloitte & Touche LLP

Share holders

87

Employees

63

Alto Neuroscience Inc. Statistics

Valuation Measures

Market Capitalization2

98.71M

Enterprise Value

-71.54M

Enterprise Value/EBITDA(ttm)

1.14

Price to Earnings Ratio(ttm)

--

Price to Sales(ttm)

--

Price to Book(mrq)

0.63

Price to Cash(ytd)

--

Profitability

Gross Margin(ttm)

0.00%

Operating Margin(ttm)

--

Profit Margin(ttm)

0.00%

Return on Equity(ttm)

-49.28%

Return on Invested Capital(ttm)

-38.98%

Return on Assets(ttm)

-33.52%

Income Statement

Revenue(ttm)

0.00

Revenue Per Share(ttm)

0.00

Gross Profit(ttm)

0.00

EBITDA(ttm)3

-62.93M

Net Income Available to Common(ttm)

-57.45M

Diluted EPS(ttm)

--

Share Statistics

Beta (5Y Monthly)

--

52-Week Change

--

S&P 500 52-Week Change

23.87%

S&P 500 Member

Yes

Stock Optionable

Yes

Total Shares Outstanding1

26.97M

Dividend Yield

0.00%

Float4

0.00

% Held by Insiders

--

% Held by Institutions

0.00%

Balance Sheet

Total Cash(mrq)

181.70M

Total Cash Per Share(mrq)

6.74

Total Debt(mrq)

11.45M

Total Debt/Equity(mrq)

6.94%

Current Ratio(mrq)

13.10%

Quick Ratio(mrq)

13.09%

Book Value Per Share(mrq)

6.12

Cash Flow

Operating Cash Flow Per Share(ytd)

-1.28

Free Cash Flow(ytd)

-35.97M

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. All numbers are rounded to the closest decimal.

  • 1 Total Shares outstanding is taken from the most recently filed quarterly or annual report.
  • 2 Market Cap is calculated using total shares outstanding and the most recent share price.
  • 3 EBITDA is calculated using methodology that may differ from that used by a company in its reporting.
  • 4 The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.
Advertisement